SMA News & Perspectives -- August 20, 2018
Aug 20, 2018, 12:00 AM
The UK's NICE rejects Spinraza for use in the NHS due to price. UK SMA groups react with anger and disappointment.
The UK's NICE rejects Spinraza for use in the NHS due to price. UK SMA groups react with anger and disappointment.
You can visit our support center if you're having problems.